Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CETP | P11597 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13413617 | 1.00 | SLC7A5 (0.42) | SLC7A5USP2SLCO1B1SLC1A3SLC1A2 | |
| SCHEMBL13413616 | 1.00 | SLC7A5 (0.42) | SLC7A5USP2SLCO1B1SLC1A3SLC1A2 | |
| SCHEMBL647205 | 1.00 | SLC7A5 (0.42) | SLC7A5USP2SLCO1B1SLC1A3SLC1A2 | |
| SCHEMBL647206 | 1.00 | SLC7A5 (0.42) | SLC7A5USP2SLCO1B1SLC1A3SLC1A2 | |
| SCHEMBL17234503 | 0.76 | SLC7A5 (0.43) | SLC7A5USP2SLCO1B1SLC1A3SLC1A2 | |
| SCHEMBL17234504 | 0.76 | SLC7A5 (0.43) | SLC7A5USP2SLCO1B1SLC1A3SLC1A2 | |
| SCHEMBL188570 | 0.76 | SLC7A5 (0.43) | SLC7A5USP2SLCO1B1SLC1A3SLC1A2 | |
| SCHEMBL18528367 | 0.76 | SLC7A5 (0.43) | SLC7A5USP2SLCO1B1SLC1A3SLC1A2 | |
| SCHEMBL18528440 | 0.76 | SLC7A5 (0.43) | SLC7A5USP2SLCO1B1SLC1A3SLC1A2 | |
| SCHEMBL188569 | 0.76 | SLC7A5 (0.43) | SLC7A5USP2SLCO1B1SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100099845-A1 | PROTECTED ENANTIOPURE TRIFLUOROTHREONINES AND METHODS OF MAKING AND USING SAME | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099845-A1 | PROTECTED ENANTIOPURE TRIFLUOROTHREONINES AND METHODS OF MAKING AND USING SAME | PTMS, DHPS, DAO | SLC7A5 247/4885USP2 2111/4885SLCO1B1 2018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.